Internal Medicine · Far Rockaway, NY
NPI
1881772044
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2004 Seagirt Blvd
Far Rockaway, NY, 11691
Phone (718) 868-8668
Groups this clinician bills Medicare through
Medicare paid, 2024
$446K
9,456 services
Medicare patients, 2024
214
Average age 78
Drug cost, 2024
$2.8M
15,863 prescriptions
Company payments, 2025
$780
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maya Rankova was code 99490 (chronic, principal, and transitional care management), 1,125 times for 137 patients. In total Maya Rankova billed 9,456 services in 75 codes, and Medicare paid $446K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-05-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,125 | 137 | $53.65 | $60K |
| 99213 Office E&M - Established | Office | 999 | 195 | $80.85 | $81K |
| 96365 Intravenous Infusion, Hydration | Office | 814 | 83 | $58.28 | $47K |
| 96366 Intravenous Infusion, Hydration | Office | 813 | 83 | $18.51 | $15K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 810 | 83 | $0.52 | $421 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 798 | 80 | $1.04 | $828 |
| 96374 Injection Administration | Office | 784 | 79 | $33.91 | $27K |
| J3475 Injection, magnesium sulfate, per 500 mg | Office | 769 | 77 | $0.47 | $362 |
| 99347 Home E&M - New and Established | Office | 353 | 30 | $39.37 | $14K |
| 99212 Office E&M - Established | Office | 248 | 129 | $50.83 | $13K |
| 51729 Other Organ Systems | Office | 153 | 77 | $352.71 | $54K |
| 51741 Test - Miscellaneous | Office | 153 | 77 | $6.56 | $1,004 |
| 51797 Other Organ Systems | Office | 153 | 77 | $174.21 | $27K |
| 99232 Hospital E&M - Subsequent | Facility | 132 | 15 | $68.76 | $9,076 |
| 94010 Pulmonary Function Testing | Office | 121 | 121 | $25.19 | $3,048 |
By year: 2022 $538K for 11,956 services; 2023 $447K for 9,725 services; 2024 $446K for 9,456 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87426 Immunoassay | 22 | 21 | $34.62 | $762 |
Medicare prescription drug claims, 2024
In 2024, the drug Maya Rankova prescribed most often to Medicare patients was Rosuvastatin Calcium, with 521 prescriptions and refills. In total Maya Rankova wrote 15,863 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 521 | 623 | 73 | $2,695 |
| Amlodipine Besylate Generic | 447 | 515 | 65 | $1,084 |
| Metoprolol Succinate Generic | 357 | 401 | 53 | $2,617 |
| Losartan Potassium Generic | 310 | 386 | 47 | $1,361 |
| Diclofenac Sodium Generic | 304 | 321 | 75 | $74K |
| Atorvastatin Calcium Generic | 290 | 362 | 49 | $1,198 |
| Synthroid Levothyroxine Sodium | 276 | 335 | 30 | $14K |
| Fluticasone Propionate Generic | 271 | 286 | 63 | $1,971 |
| Pantoprazole Sodium Generic | 235 | 255 | 34 | $1,119 |
| Tamsulosin Hcl Generic | 231 | 251 | 36 | $1,403 |
| Famotidine Generic | 224 | 247 | 39 | $1,011 |
| Eliquis Apixaban | 220 | 230 | 43 | $138K |
| Clopidogrel Clopidogrel Bisulfate | 219 | 249 | 36 | $813 |
| Vascepa Icosapent Ethyl | 213 | 213 | 26 | $71K |
| Myrbetriq Mirabegron | 206 | 214 | 25 | $96K |
Brand drugs: 4,162 claims; generic drugs: 11,285 claims; opioid claims: 50.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maya Rankova $780 ($780 in general payments such as food, travel and fees) from 13 companies. The largest payer was Eisai Inc. with $160.
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. 4523.T | 6 | $160 |
| Abbvie Inc. ABBV | 4 | $97.06 |
| Merck Sharp & Dohme LLC MRK | 4 | $90.51 |
| Axsome Therapeutics, Inc. AXSM | 3 | $87.22 |
| Amgen Inc. AMGN | 3 | $61.63 |
| Aimmune Therapeutics, Inc. | 2 | $48.66 |
| Sumitomo Pharma America, Inc. 4506.T | 2 | $42.88 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $39.96 |
| Esperion Therapeutics, Inc. ESPR | 2 | $37.67 |
| Novo Nordisk Inc NVO | 2 | $35.74 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.